RESX

RestorGenex CorpCIK 1053691 ☆ Sign in to watch Congress trades

Open-mkt buys · 90d

—

0 trades · 0 insiders

Open-mkt sales · 90d

—

0 trades · 0 insiders

Net · 90d

Insiders on file

AI insights for RESX PRO

XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%
XXXX	$█.██M	██	+██%

AI insights for RESX

Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.

Upgrade to Pro · $99/year Already Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

Insider	Role	Trades	Bought	Sold	Last trade
Kalergis David G	Chairman and CEO	11	$0	$0	2016-01-08
Byrne Thomas S	Director	10	$0	$0	2016-01-08
Giles Mark T	Director	7	$0	$0	2016-01-08
Adams Robert W	Director	7	$0	$0	2016-01-08
Gainer John	Chief Scientific Officer	10	$0	$0	2016-01-08
LEVIN ALAN G	Director	3	$0	$0	2016-01-08
Weinberg Mark A.	Sr. V.P.- Clinical Development	1	$0	$0	2014-08-04
BLECH ISAAC	Director	2	$0	$0	2014-07-24
SIMES STEPHEN M	Chief Executive Officer	1	$0	$0	2014-07-24
Boris Timothy	Director	1	$0	$0	2014-07-24
Schwartz Yael	President of Subsidiaries	2	$0	$0	2014-07-24
STACKS NELSON K.	Director	1	$0	$0	2014-07-24
Bright Rex	Director	1	$0	$0	2014-07-24
BARER SOL J	Director	16	$0	$0	2014-07-24
DONENBERG PHILIP B	Director	2	$0	$0	2014-07-24
SHERRIS DAVID	Chief Scientific Officer	2	$0	$0	2014-07-24
Abolin Craig	VP of Research & Dev - Subsid.	1	$0	$0	2014-06-03

Trade history

Insider	Role	Code	Trade	Filed	Shares	Price	Value	Owned after
Gainer John	Chief Scientific Officer	A Award deriv	2016-01-08	2016-01-12	109,579	—	$0	109,579	SEC↗
Gainer John	Chief Scientific Officer	A Award deriv	2016-01-08	2016-01-12	182,632	—	$0	182,632	SEC↗
Gainer John	Chief Scientific Officer	A Award deriv	2016-01-08	2016-01-12	91,316	—	$0	91,316	SEC↗
Gainer John	Chief Scientific Officer	A Award deriv	2016-01-08	2016-01-12	219,159	—	$0	219,159	SEC↗
Gainer John	Chief Scientific Officer	A Award deriv	2016-01-08	2016-01-12	182,632	—	$0	182,632	SEC↗
Gainer John	Chief Scientific Officer	A Award deriv	2016-01-08	2016-01-12	182,632	—	$0	182,632	SEC↗
Gainer John	Chief Scientific Officer	A Award deriv	2016-01-08	2016-01-12	91,316	—	$0	91,316	SEC↗
Gainer John	Chief Scientific Officer	A Award deriv	2016-01-08	2016-01-12	226,486	—	$0	226,486	SEC↗
Gainer John	Chief Scientific Officer	A Award deriv	2016-01-08	2016-01-12	365,265	—	$0	365,265	SEC↗
LEVIN ALAN G	Director	A Award deriv	2016-01-08	2016-01-12	276,140	—	$0	276,140	SEC↗
LEVIN ALAN G	Director	A Award deriv	2016-01-08	2016-01-12	365,265	—	$0	365,265	SEC↗
Giles Mark T	Director	A Award deriv	2016-01-08	2016-01-12	365,265	—	$0	365,265	SEC↗
Giles Mark T	Director	A Award deriv	2016-01-08	2016-01-12	182,632	—	$0	182,632	SEC↗
Giles Mark T	Director	A Award deriv	2016-01-08	2016-01-12	182,632	—	$0	182,632	SEC↗
Giles Mark T	Director	A Award deriv	2016-01-08	2016-01-12	98,621	—	$0	98,621	SEC↗
Giles Mark T	Director	A Award deriv	2016-01-08	2016-01-12	91,316	—	$0	91,316	SEC↗
Adams Robert W	Director	A Award deriv	2016-01-08	2016-01-12	186,285	—	$0	186,285	SEC↗
Adams Robert W	Director	A Award deriv	2016-01-08	2016-01-12	91,316	—	$0	91,316	SEC↗
Adams Robert W	Director	A Award deriv	2016-01-08	2016-01-12	182,632	—	$0	182,632	SEC↗
Adams Robert W	Director	A Award deriv	2016-01-08	2016-01-12	182,632	—	$0	182,632	SEC↗
Adams Robert W	Director	A Award deriv	2016-01-08	2016-01-12	365,265	—	$0	365,265	SEC↗
Byrne Thomas S	Director	A Award deriv	2016-01-08	2016-01-12	36,526	—	$0	36,526	SEC↗
Byrne Thomas S	Director	A Award deriv	2016-01-08	2016-01-12	215,506	—	$0	215,506	SEC↗
Byrne Thomas S	Director	A Award deriv	2016-01-08	2016-01-12	91,316	—	$0	91,316	SEC↗
Byrne Thomas S	Director	A Award deriv	2016-01-08	2016-01-12	109,579	—	$0	109,579	SEC↗
Byrne Thomas S	Director	A Award deriv	2016-01-08	2016-01-12	237,422	—	$0	237,422	SEC↗
Byrne Thomas S	Director	A Award deriv	2016-01-08	2016-01-12	182,632	—	$0	182,632	SEC↗
Byrne Thomas S	Director	A Award deriv	2016-01-08	2016-01-12	182,632	—	$0	182,632	SEC↗
Byrne Thomas S	Director	A Award deriv	2016-01-08	2016-01-12	182,632	—	$0	182,632	SEC↗
Byrne Thomas S	Director	A Award deriv	2016-01-08	2016-01-12	365,265	—	$0	365,265	SEC↗
Kalergis David G	Chairman and CEO	A Award deriv	2016-01-08	2016-01-13	182,632	—	$0	182,632	SEC↗
Kalergis David G	Chairman and CEO	A Award deriv	2016-01-08	2016-01-13	182,632	—	$0	182,632	SEC↗
Kalergis David G	Chairman and CEO	A Award deriv	2016-01-08	2016-01-13	127,843	—	$0	127,843	SEC↗
Kalergis David G	Chairman and CEO	A Award deriv	2016-01-08	2016-01-13	331,595	—	$0	331,595	SEC↗
Kalergis David G	Chairman and CEO	A Award deriv	2016-01-08	2016-01-13	91,316	—	$0	91,316	SEC↗
Kalergis David G	Chairman and CEO	A Award deriv	2016-01-08	2016-01-13	295,865	—	$0	295,865	SEC↗
Kalergis David G	Chairman and CEO	A Award deriv	2016-01-08	2016-01-13	127,843	—	$0	127,843	SEC↗
Kalergis David G	Chairman and CEO	A Award deriv	2016-01-08	2016-01-13	365,265	—	$0	365,265	SEC↗
Kalergis David G	Chairman and CEO	A Award deriv	2016-01-08	2016-01-13	273,949	—	$0	273,949	SEC↗
Gainer John	Chief Scientific Officer	A Award	2016-01-08	2016-01-12	3,725,711	—	$0	3,725,711	SEC↗
LEVIN ALAN G	Director	A Award	2016-01-08	2016-01-12	248,032	—	$0	248,032	SEC↗
Giles Mark T	Director	A Award	2016-01-08	2016-01-12	6,296,346	—	$0	6,296,346	SEC↗
Giles Mark T	Director	A Award	2016-01-08	2016-01-12	44,069	—	$0	44,069	SEC↗
Adams Robert W	Director	A Award	2016-01-08	2016-01-12	188,973	—	$0	188,973	SEC↗
Adams Robert W	Director	A Award	2016-01-08	2016-01-12	350,504	—	$0	350,504	SEC↗
Byrne Thomas S	Director	A Award	2016-01-08	2016-01-12	1,391,867	—	$0	1,391,867	SEC↗
Kalergis David G	Chairman and CEO	A Award	2016-01-08	2016-01-13	1,069,216	—	$0	1,069,216	SEC↗
Kalergis David G	Chairman and CEO	A Award	2016-01-08	2016-01-13	215,506	—	$0	215,506	SEC↗
Weinberg Mark A.	Sr. V.P.- Clinical Developme	A Award deriv	2014-08-04	2014-08-06	521,475	—	$0	521,475	SEC↗
BARER SOL J	Director	A Award deriv	2014-07-24	2014-07-29	123,287	—	$0	123,287	SEC↗
BLECH ISAAC	Director	A Award deriv	2014-07-24	2014-07-29	87,449	—	$0	87,449	SEC↗
Boris Timothy	Director	A Award deriv	2014-07-24	2014-07-29	79,655	—	$0	79,655	SEC↗
Bright Rex	Director	A Award deriv	2014-07-24	2014-07-29	61,085	—	$0	61,085	SEC↗
DONENBERG PHILIP B	Director	A Award deriv	2014-07-24	2014-07-29	271,475	—	$0	271,475	SEC↗
Schwartz Yael	Exe. VP Preclinical Dev.	A Award deriv	2014-07-24	2014-07-29	119,482	—	$0	119,482	SEC↗
SHERRIS DAVID	Chief Scientific Officer	A Award deriv	2014-07-24	2014-07-29	119,482	—	$0	119,482	SEC↗
SIMES STEPHEN M	Chief Executive Officer	A Award deriv	2014-07-24	2014-07-29	542,975	—	$0	542,975	SEC↗
STACKS NELSON K.	Director	A Award deriv	2014-07-24	2014-07-29	61,374	—	$0	61,374	SEC↗
BARER SOL J	Chairman of the Board	A Award deriv	2014-06-06	2014-06-10	202,962	—	$0	202,962	SEC↗
BARER SOL J	Chairman of the Board	C Conversion deriv	2014-06-06	2014-06-10	78,473	—	$0	0	SEC↗
BARER SOL J	Chairman of the Board	C Conversion deriv	2014-06-06	2014-06-10	76,755	—	$0	0	SEC↗
BARER SOL J	Chairman of the Board	A Award deriv	2014-06-06	2014-06-10	57,566	—	$0	57,566	SEC↗
BARER SOL J	Chairman of the Board	C Conversion deriv	2014-06-06	2014-06-10	270,606	—	$0	0	SEC↗
BARER SOL J	Chairman of the Board	C Conversion deriv	2014-06-06	2014-06-10	126,894	—	$0	0	SEC↗
BARER SOL J	Chairman of the Board	A Award deriv	2014-06-06	2014-06-10	95,170	—	$0	95,170	SEC↗
BARER SOL J	Chairman of the Board	C Conversion	2014-06-06	2014-06-10	270,616	$2.00	$541.2K	46,103,949	SEC↗
BARER SOL J	Chairman of the Board	C Conversion	2014-06-06	2014-06-10	78,473	$2.00	$156.9K	46,182,422	SEC↗
BARER SOL J	Chairman of the Board	C Conversion	2014-06-06	2014-06-10	126,894	$2.00	$253.8K	46,386,071	SEC↗
BARER SOL J	Chairman of the Board	C Conversion	2014-06-06	2014-06-10	76,755	$2.00	$153.5K	46,259,177	SEC↗
BARER SOL J	Chairman of the Board	C Conversion	2014-06-06	2014-06-19	78,473	$2.00	$156.9K	807,423	SEC↗
BARER SOL J	Chairman of the Board	C Conversion	2014-06-06	2014-06-19	76,755	$2.00	$153.5K	884,178	SEC↗
BARER SOL J	Chairman of the Board	C Conversion	2014-06-06	2014-06-19	126,894	$2.00	$253.8K	1,011,072	SEC↗
BARER SOL J	Chairman of the Board	C Conversion	2014-06-06	2014-06-19	270,616	$2.00	$541.2K	728,950	SEC↗
Schwartz Yael	President of Subsidiaries	A Award deriv	2014-06-03	2014-06-12	115,193	—	$0	115,193	SEC↗
Abolin Craig	VP of Research & Dev - Subsi	A Award deriv	2014-06-03	2014-06-12	57,596	—	$0	57,596	SEC↗
SHERRIS DAVID	CSO & President of Division	A Award deriv	2014-06-03	2014-06-12	115,193	—	$0	115,193	SEC↗
DONENBERG PHILIP B	Chief Financial Officer	A Award deriv	2014-05-27	2014-06-06	250,000	—	$0	250,000	SEC↗
BLECH ISAAC	Director	A Award deriv	2014-01-07	2015-09-21	17,441	—	$0	17,441	SEC↗